Skip to content

Clinical trials

Inflammatory Bowel Diseases trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Country / region: Bulgaria Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20114
20141
20152
20181
20191
20205
20221
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated5
Recruiting3
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC3
Theravance Biopharma3
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)2
4SC AG1
AbbVie1
Amgen1
Applied Molecular Transport1
GlaxoSmithKline1
Merck Sharp & Dohme LLC1
OSE Immunotherapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases20
Colitis, Ulcerative11
Crohn Disease9
Colitis3
Gastrointestinal Diseases1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.